论文标题
基于MRI的鉴别诊断对阿尔茨海默氏病和额颞痴呆的深度分级
Deep grading for MRI-based differential diagnosis of Alzheimer's disease and Frontotemporal dementia
论文作者
论文摘要
阿尔茨海默氏病和额颞痴呆是神经退行性痴呆的常见形式。在疾病的临床课程中发现行为改变和认知障碍,有时很难对医生进行鉴别诊断。因此,专门针对此诊断挑战的准确工具在临床实践中可能很有价值。但是,当前的结构成像方法主要集中于每种疾病的检测,但很少介绍其鉴别诊断。在本文中,我们提出了一种基于深度学习的方法,以解决疾病检测问题和鉴别诊断问题。我们建议利用两种类型的生物标志物进行此应用:结构分级和结构萎缩。首先,我们建议训练大型3D U-NET的合奏,以确定健康人的解剖模式,患有阿尔茨海默氏病的患者以及使用结构MRI作为输入的额颞痴呆患者。合奏的输出是一个2通道疾病的坐标图,可以转换为3D分级图,对于临床医生来说很容易解释。此2通道图与用于不同分类任务的多层感知器分类器结合在一起。其次,我们建议将我们的深度学习框架与基于数量的传统机器学习策略相结合,以提高模型歧视能力和鲁棒性。经过交叉验证和外部验证后,我们基于3319 MRI的实验与疾病检测和差异诊断的最新方法相比,我们的方法表现出竞争性的结果。
Alzheimer's disease and Frontotemporal dementia are common forms of neurodegenerative dementia. Behavioral alterations and cognitive impairments are found in the clinical courses of both diseases and their differential diagnosis is sometimes difficult for physicians. Therefore, an accurate tool dedicated to this diagnostic challenge can be valuable in clinical practice. However, current structural imaging methods mainly focus on the detection of each disease but rarely on their differential diagnosis. In this paper, we propose a deep learning based approach for both problems of disease detection and differential diagnosis. We suggest utilizing two types of biomarkers for this application: structure grading and structure atrophy. First, we propose to train a large ensemble of 3D U-Nets to locally determine the anatomical patterns of healthy people, patients with Alzheimer's disease and patients with Frontotemporal dementia using structural MRI as input. The output of the ensemble is a 2-channel disease's coordinate map able to be transformed into a 3D grading map which is easy to interpret for clinicians. This 2-channel map is coupled with a multi-layer perceptron classifier for different classification tasks. Second, we propose to combine our deep learning framework with a traditional machine learning strategy based on volume to improve the model discriminative capacity and robustness. After both cross-validation and external validation, our experiments based on 3319 MRI demonstrated competitive results of our method compared to the state-of-the-art methods for both disease detection and differential diagnosis.